PCPA makes submissions to government on proposed changes to law and policy which affects cancer physicians and patients in Australia.
A joint submission to The Health Technology Assessment (HTA) Policy and Methods Review - Consultation 2
February 26, 2024
This submission has been prepared jointly between Cancer Council Australia (Cancer Council), the Cancer Nurses Society of Australia (CNSA), the Clinical Oncology Society of Australia (COSA), Private Cancer Physicians of Australia (PCPA) and Medical Oncology Group of Australia (MOGA).
Submission to TGA for Medicines Repurposing Program
February 05, 2024
The Private Cancer Physicians of Australia welcomes the invitation to contribute to the Therapeutic Goods Administration’s proposed framework and criteria presented in the Medicines Repurposing Program implementation update and targeted consultation paper.
The issue of repurposing is complex.
The reasons behind the lack of PBAC approval for each individual medicine is different.
Australian Cancer Nursing and Navigation Program
November 2023
The PCPA are pleased to announce that after two years of dedicated advocacy with Rare Cancers Australia, our recommendation of dedicated and experienced (nurse) navigators for all cancer patients has been adopted in the National Cancer Plan. Further, the Government has supported this with $166m for the Australian Cancer Nursing and Navigation Program.
PCPA Response to Telehealth Draft Report
6th November 2023
A joint submission to The Senate Standing Committee on Community Affairs: Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer
28th August 2023
A joint submission to The Health Technology Assessment (HTA) Policy and Methods Review
6th June 2023
Review of the Efficient Funding of Chemotherapy (EFC) program
July 2021